New, non-invasive imaging tool maps uterine contractions during labor
On Mar. 14, 2023, NIH researchers announced they had developed a new imaging tool, called electromyometrial imaging (EMMI),…
Moderna to make milestone payments to NIH for COVID vaccine
On Feb. 24, 2023, Moderna announced will make certain contingent development, commercial and regulatory milestone payments to the…
NIH software assembled complete genome sequences on-demand
On Feb. 16, 2023, National Institutes of Health (NIH) scientists announced they had developed and released an innovative…
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
FDA authorized first Mpox test
On Feb. 10, 2023, the U.S. Food and Drug Administration issued an emergency use authorization for the first…
Large-scale genetic analysis showed microRNAs in human pancreas associated with diabetes
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
Bivalent boosters provided better protection against severe COVID-19
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
Biotechnology | Disease | Life Science News | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
New MRI method provided detailed view of the placenta during pregnancy
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
Biotechnology | HIV | Life Science News | NIH | Vaccine
Experimental HIV vaccine regimen safe but ineffective, study found
On Jan. 18, 2023, the National Institutes of Health (NIH) announced that an investigational HIV vaccine regimen tested…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | NIH | Therapeutics
NIH researchers unlocked pattern of gene activity for ADHD
On Nov. 16, 2022, resarchers at the National Institutes of Health (NIH) announced they had successfully identified differences…
First ever clinical trial of laboratory grown red blood cells being transfused into another person
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
Biotechnology | COVID-19 | Diagnostics | Disease | Life Science News | NIH | Therapeutics
NIH-funded study showed blood pressure levels rose during pandemic
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
NIH awarded USC $11.7 million to develop implantable devices for the nervous system
On Oct. 26, 2022, the NIH announced it had awarded the University of Southern California (USC) $11.7 million…
NIH awarded University of Missouri $8 million grant to expand National Swine Resource and Research Center
On Oct. 25, 2022, the National Institutes of Health (NIH) announced that the University of Missouri had been…
Biotechnology | HIV | Life Science News | NIH
Early HIV diagnosis and treatment important for better long-term health outcomes
On Oct. 24, 2022, the National Institutes of Health announced that starting antiretroviral treatment (ART) early in the…
Biotechnology | HIV | Life Science News | NIH | Vaccine
Three-dose hepatitis B vaccine regimen protected people with HIV
On Oct. 20, 2022, the National Institutes of Health announced that a three-dose course of the hepatitis B…
Study confirmed link between COVID-19 vaccination and temporary increase in menstrual cycle length
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Therapeutics
NIH established initiative to systematically investigate and establish function of every human gene
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
Salk Institute to lead $126 million effort to map the aging human brain
On Supt. 22, 2022, with a five-year, $126 million grant from the National Institutes of Health (NIH), a…
NIH-funded team developed method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance
On Sept. 15, 2022, the National Institutes of Health announced that a research team funded by the NIH…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Life Science News | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Vacations Redux
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
Vaccine-induced immune response to Omicron wanes substantially over time
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
COVID-19 | Life Science News | NIH | Therapeutics | Vaccine
U.S. Government secured 3.2 million doses of Novavax COVID-19 vaccine
On Jul. 11, 2022, Novavax announced an agreement with the U.S. Department of Health and Human Services (HHS),…
NIH launched clinical trial of mRNA Nipah virus vaccine
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
COVID-19 was third leading cause of death in the United States in both 2020 and 2021
On Jul. 5, 2022, the National Institutes of Health and National Cancer Institute announced COVID-19 was the third…
Trial of potential universal flu vaccine opened at NIH Clinical Center
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
Biotechnology | Disease | Medicine | NIH | Ophthalmogy | Therapeutics
NIH study confirmed benefit of supplements for slowing age-related macular degeneration
On Jun. 2, 2022, the National Institutes of Health (NIH) reported that the Age-Related Eye Disease Studies (AREDS…